{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:51:29Z","timestamp":1769554289271,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22475168"],"award-info":[{"award-number":["22475168"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22275144"],"award-info":[{"award-number":["22275144"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017596","name":"Natural Science Basic Research Program of Shaanxi Province","doi-asserted-by":"publisher","award":["S2025-JC-QYXQ-0051"],"award-info":[{"award-number":["S2025-JC-QYXQ-0051"]}],"id":[{"id":"10.13039\/501100017596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031935","name":"Xi'an Jiaotong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031935","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["xzy012024051"],"award-info":[{"award-number":["xzy012024051"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijbiomac.2025.149889","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:07:28Z","timestamp":1766534848000},"page":"149889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Neutrophil-derived proteoliposomes loading doxorubicin and porphyrin for targeted chemo-phototherapy of triple-negative breast cancers"],"prefix":"10.1016","volume":"339","author":[{"given":"Xin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mufan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longlong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhishen","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingdi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huadong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149889_bb0005","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149889_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149889_bb0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13578-025-01359-0","article-title":"Classifications of triple-negative breast cancer: insights and current therapeutic approaches","volume":"15","author":"Chen","year":"2025","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149889_bb0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/PPO.0000000000000498","article-title":"Adjuvant and neoadjuvant treatment of triple-negative breast Cancer with chemotherapy","volume":"27","author":"Marra","year":"2021","journal-title":"Cancer J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149889_bb0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil(R)--the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149889_bb0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12012-024-09952-4","article-title":"Doxorubicin or Epirubicin versus liposomal doxorubicin therapy-differences in cardiotoxicity","volume":"25","author":"Buchalska","year":"2025","journal-title":"Cardiovasc. Toxicol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149889_bb0035","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/j.clbc.2017.10.005","article-title":"Phase I\/II trial of combined Pegylated liposomal doxorubicin and cyclophosphamide in metastatic breast Cancer","volume":"18","author":"Chang","year":"2018","journal-title":"Clin. Breast Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149889_bb0040","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jconrel.2013.08.034","article-title":"Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro\/in vivo live cell imaging","volume":"172","author":"Seynhaeve","year":"2013","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149889_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030893","article-title":"Recent preclinical and clinical Progress in liposomal doxorubicin","volume":"15","author":"Aloss","year":"2023","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149889_bb0050","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2174\/1389201023666220309154439","article-title":"Immunoliposomes: a targeted drug delivery system for Cancer therapeutics and vaccination","volume":"24","author":"Gupta","year":"2023","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.149889_bb0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.addr.2020.09.003","article-title":"When liposomes met antibodies: drug delivery and beyond","volume":"154-155","author":"Di","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149889_bb0060","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41565-024-01620-6","article-title":"Chimeric nanobody-decorated liposomes by self-assembly","volume":"19","author":"Rahman","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ijbiomac.2025.149889_bb0065","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jconrel.2022.06.039","article-title":"Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression","volume":"348","author":"Kim","year":"2022","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.149889_bb0070","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/17425247.2018.1517747","article-title":"Clinical translation of immunoliposomes for cancer therapy: recent perspectives","volume":"15","author":"Wang","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.149889_bb0075","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4939-7312-5_19","article-title":"Preparation of Immunoliposomes by direct coupling of antibodies based on a Thioether bond","volume":"1674","author":"Petrilli","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149889_bb0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"Pt 2","key":"10.1016\/j.ijbiomac.2025.149889_bb0085","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.semcancer.2022.04.007","article-title":"Biomimetic approaches for targeting tumor-promoting inflammation","volume":"86","author":"Parodi","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149889_bb0090","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12951-021-00986-2","article-title":"Artificial exosomes for translational nanomedicine","volume":"19","author":"Li","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.149889_bb0095","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/nmat4644","article-title":"Biomimetic proteolipid vesicles for targeting inflamed tissues","volume":"15","author":"Molinaro","year":"2016","journal-title":"Nat. Mater."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.149889_bb0100","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1016\/j.apsb.2023.05.019","article-title":"Engineering cannabidiol synergistic carbon monoxide nanocomplexes to enhance cancer therapy via excessive autophagy","volume":"13","author":"Xiao","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.149889_bb0105","first-page":"5864","article-title":"A Pluripotential neutrophil-mimic Nanovehicle modulates immune microenvironment with targeted drug delivery for augmented antitumor chemotherapy","volume":"18","author":"Wu","year":"2024","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.149889_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188762","article-title":"Tumor-associated neutrophils and neutrophil-targeted cancer therapies","volume":"1877","author":"Que","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149889_bb0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","article-title":"Neutrophils in cancer: heterogeneous and multifaceted","volume":"22","author":"Hedrick","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.149889_bb0120","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nchem.2236","article-title":"Functionalization of cobalt porphyrin-phospholipid bilayers with his-tagged ligands and antigens","volume":"7","author":"Shao","year":"2015","journal-title":"Nat. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.149889_bb0125","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2174\/2211738508666200813141454","article-title":"A novel Long-circulating DOX liposome: formulation and pharmacokinetics studies","volume":"8","author":"Xiao","year":"2020","journal-title":"Pharm. Nanotechnol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.149889_bb0130","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/cac2.12579","article-title":"\u201cfind me\u201d and \u201ceat me\u201d signals: tools to drive phagocytic processes for modulating antitumor immunity","volume":"44","author":"Xiao","year":"2024","journal-title":"Cancer Commun."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149889_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065278","article-title":"Dialog beyond the grave: necrosis in the tumor microenvironment and its contribution to tumor growth","volume":"24","author":"Zapletal","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149889_bb0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jconrel.2013.02.026","article-title":"A simple way to enhance Doxil(R) therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer","volume":"168","author":"Zhao","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.149889_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120117","article-title":"Liposomal doxorubicin as targeted delivery platform: current trends in surface functionalization","volume":"593","author":"Makwana","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.149889_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122369","article-title":"Biomimetic Prussian blue nanocomplexes for chemo-photothermal treatment of triple-negative breast cancer by enhancing ICD","volume":"303","author":"Long","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2025.149889_bb0155","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jconrel.2022.05.027","article-title":"Exosomes: large-scale production, isolation, drug loading efficiency, and biodistribution and uptake","volume":"347","author":"Kimiz-Gebologlu","year":"2022","journal-title":"J. Control. Release"},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.149889_bb0160","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.7150\/thno.15701","article-title":"Sphingomyelin liposomes containing porphyrin-phospholipid for irinotecan Chemophototherapy","volume":"6","author":"Carter","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2025.149889_bb0165","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jconrel.2022.06.039","article-title":"Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression","volume":"348","author":"Kim","year":"2022","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.149889_bb0170","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.biomaterials.2013.11.083","article-title":"A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy","volume":"35","author":"Tian","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2025.149889_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122687","article-title":"Tumor-derived nanovesicles enhance cancer synergistic chemo-immunotherapy by promoting cGAS\/STING pathway activation and immunogenetic cell death","volume":"348","author":"Guo","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.ijbiomac.2025.149889_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122869","article-title":"Engineering cell membrane-camouflaged COF-based nanosatellite for enhanced tumor-targeted photothermal chemoimmunotherapy","volume":"314","author":"Lin","year":"2025","journal-title":"Biomaterials"},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.149889_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202310318","article-title":"Engineering and targeting neutrophils for Cancer therapy","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.149889_bb0190","article-title":"Living leukocyte-based drug delivery systems","volume":"35","author":"Chen","year":"2023","journal-title":"Adv. Mater."},{"issue":"22","key":"10.1016\/j.ijbiomac.2025.149889_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201734","article-title":"Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149889_bb0200","article-title":"Immunostimulatory properties of chemotherapy in breast Cancer: from immunogenic modulation mechanisms to clinical practice","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.149889_bb0205","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.canlet.2018.01.050","article-title":"Immunogenic chemotherapy: dose and schedule dependence and combination with immunotherapy","volume":"419","author":"Wu","year":"2018","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149889_bb0210","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2272352","article-title":"Immunogenic chemotherapy sensitizes RAS-mutated colorectal cancers to immune checkpoint inhibitors","volume":"12","author":"Bezu","year":"2023","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149889_bb0215","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2098658","article-title":"A nanoparticle-based tour de force for enhancing immunogenic cell death elicited by photodynamic therapy","volume":"11","author":"Kepp","year":"2022","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.149889_bb0220","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nmat2986","article-title":"Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents","volume":"10","author":"Lovell","year":"2011","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ijbiomac.2025.149889_bb0225","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.biomaterials.2015.10.027","article-title":"Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release","volume":"75","author":"Luo","year":"2016","journal-title":"Biomaterials"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025104467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025104467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:25:52Z","timestamp":1769505952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025104467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":45,"alternative-id":["S0141813025104467"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149889","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophil-derived proteoliposomes loading doxorubicin and porphyrin for targeted chemo-phototherapy of triple-negative breast cancers","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149889","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"149889"}}